VANGUARD GROUP INC - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 35 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$924,092
-0.7%
674,520
-0.7%
0.00%
Q2 2023$930,993
-41.9%
679,5570.0%0.00%
Q1 2023$1,603,754
+3.5%
679,5570.0%0.00%
Q4 2022$1,549,390
-17.4%
679,557
+0.0%
0.00%
Q3 2022$1,875,000
+13.2%
679,2430.0%0.00%
Q2 2022$1,657,000
-38.1%
679,2430.0%0.00%
Q1 2022$2,676,000
-9.4%
679,243
+1.4%
0.00%
Q4 2021$2,953,000
-28.7%
669,700
-0.1%
0.00%
Q3 2021$4,143,000
+149.7%
670,513
+219.7%
0.00%
Q2 2021$1,659,000
-32.6%
209,750
-8.8%
0.00%
Q1 2021$2,461,000230,0440.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CM Management, LLC 225,000$549,0000.58%
BVF INC/IL 2,326,710$5,677,0000.27%
Cormorant Asset Management, LP 1,305,095$3,184,0000.24%
Ikarian Capital, LLC 362,537$884,0000.16%
JMAC ENTERPRISES LLC 54,538$133,0000.03%
Woodline Partners LP 516,675$1,261,0000.02%
Eversept Partners, LP 59,065$144,1190.01%
INGALLS & SNYDER LLC 51,149$125,0000.01%
Point72 Asset Management, L.P. 428,360$1,045,0000.00%
BAILARD, INC. 27,413$67,0000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders